Advances in GLP-1 treatment: focus on oral semaglutide

被引：0
|
作者：
Freddy G. Eliaschewitz
Luis Henrique Canani
机构：
[1] Avenida Angélica,CPClin/DASA Clinical Research Center
[2] University of Rio Grande Do Sul,Endocrinology Division of Hospital de Clínicas de Porto Alegre and Department of Internal Medicine, Medical School of Federal
来源：
Diabetology & Metabolic Syndrome | / 13卷
关键词：
Oral semaglutide; Glycemic control; GLP-1 RA; PIONEER program; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Advances in GLP-1 treatment: focus on oral semaglutide
    Eliaschewitz, Freddy G.
    Canani, Luis Henrique
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01):
  • [2] The development of oral semaglutide, an oral GLP-1 analog, for the treatment of type 2 diabetes
    Rasmussen, Mads Frederik
    [J]. DIABETOLOGY INTERNATIONAL, 2020, 11 (02) : 76 - 86
  • [3] The development of oral semaglutide, an oral GLP-1 analog, for the treatment of type 2 diabetes
    Mads Frederik Rasmussen
    [J]. Diabetology International, 2020, 11 : 76 - 86
  • [4] Oral Semaglutide: A New GLP-1 Receptor Agonist Product for the Treatment of Type 2 Diabetes
    Smith, Connor K.
    Neumiller, Joshua J.
    [J]. US PHARMACIST, 2019, 44 (10) : 36 - 45
  • [5] Oral Semaglutide: First-in-Class Oral GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes Mellitus
    Cowart, Kevin
    [J]. ANNALS OF PHARMACOTHERAPY, 2020, 54 (05) : 478 - 485
  • [6] Semaglutide GLP-1 receptor agonist Treatment of type 2 diabetes
    Chudleigh, R.
    Bain, S. C.
    [J]. DRUGS OF THE FUTURE, 2017, 42 (08) : 479 - 487
  • [7] Oral GLP-1 Modulators for the Treatment of Diabetes
    Edmonds, David J.
    Price, David A.
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 48, 2013, 48 : 119 - 130
  • [8] Treatment of Binge Eating Disorder With the GLP-1 Agonist Semaglutide: A Retrospective Cohort Study
    Richards, Jesse
    [J]. NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 40 - 41
  • [9] Semaglutide and GLP-1 analogues as weight-loss agents
    Kluger, Aaron Y.
    McCullough, Peter A.
    [J]. LANCET, 2018, 392 (10148): : 615 - 616
  • [10] Semaglutide and Other GLP-1 Agonists: A Boon for the Arthroplasty Industry?
    Magruder, Matthew L.
    Jacofsky, David
    Springer, Bryan
    Scuderi, Giles R.
    Hameed, Daniel
    Mont, Michael A.
    [J]. JOURNAL OF ARTHROPLASTY, 2024, 39 (02): : 277 - 282
12345